C07C 55/20
Sebacic acid
C07C55/20 (Sebacic acid) appears on 21 US grants and 22 published applications in this corpus.
Search patents in C07C- Granted patents
- 21
- Published applications
- 22
- Assignees
- 15
- Inventors
- 53
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 2 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Salts of nitrogen-containing heterocyclic compound, and solid forms of salts, pharmaceutical composition and use thereof26 May 2026US 12,637,470 B2Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
- Crystalline forms of tenofovir alafenamide21 Jan 2025US 12,202,849 B2Gilead Sciences, Inc.
- Decanedioic acid produced by microbial fermentation process and preparation method thereof31 Oct 2023US 11,802,298 B2Cathay Biotech Inc.
- Crystalline forms of tenofovir alafenamide13 Sep 2022US 11,440,928 B2Gilead Sciences, Inc.
- Decanedioic acid produced by microbial fermentation process and preparation method thereof1 Dec 2020US 10,851,394 B2Cathay Biotech Inc.
- Crystalline forms of tenofovir alafenamide6 Aug 2026US 2026/0226087 A1Gilead Sciences, Inc.
- Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine7 May 2026US 2026/0125345 A1
- Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof2 Apr 2026US 2026/0092037 A1Praxis Precision Medicines, Inc.
- Crystalline forms of tenofovir alafenamide3 Jul 2025US 2025/0215031 A1Gilead Sciences, Inc.
- Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine20 Mar 2025US 2025/0091993 A1Terran Biosciences Inc.
Most cited
By later US patents
- New salts useful as corrosion inhibitors11US 4,589,992 ACiba-Geigy Corporation · 1986
- Acicular aluminium salts of carboxylic acids and processes for their preparation10US 4,327,032 ACiba-Geigy Corporation · 1982
- Salt of oxaalkylenediamine with dicarboxylic acid, containing hydrazine, preparation, and nylon prepared therefrom6US 4,713,437 ABASF SE · 1987
- Purification of polycarboxylic acids5US 9,517,996 B2Verdezyne, Inc. · 2016
- Salts useful as corrosion inhibitors4US 4,740,331 ACiba-Geigy Corporation · 1988